1,010
Participants
Start Date
June 30, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
December 31, 2016
Coronary stenting
The PROMUS™ Element™ Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length (8 mm, 12 mm, 16 mm, 20 mm, 24 mm, 28 mm, 32 mm, 38mm) with a reference vessel diameter of 2.25 mm - 4.0 mm.
Virga Jesse Ziekenhuis, Hasselt
Roskilde Sygehus, Roskilde
Klinikum Wels-Grieskirchen, Wels
Odense University Hospital, Odense
Dept. of Internal Medicine and Cardiological Center, Szeged
Hospital Universitari Germans Trias i Pujol, Barcelona
Centre Hospitalier Privé Saint Martin gds, Caen
Centro Cardiologico Monzino, Milan
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH, Bad Segeberg
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
IRCCS Policlinico S. Matteo, Pavia
Hospital Universitario La Paz, Madrid
Med. Hochschule Hannover, Hanover
Clinique Pasteur, Toulouse
Clinique St. Martin, Pessac
Universitätsklinikum Düsseldorf, Düsseldorf
Klinikum Leverkusen, Leverkusen
Universitätsklinikum Bonn, Bonn
Klinikum Darmstadt, Darmstadt
Clinique Saint-Hilaire Rouen, Rouen
Schwarzwald Baar Klinikum Villingen-Schwenningen, Villingen-Schwenningen
Clinica Mediterranea, Napoli
Polyclinique les Fleurs, Ollioules
Le Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson
Zentralklinik Bad Berka GmbH, Bad Berka
Allgemeines Krankenhaus der Stadt Linz, Linz
Medizinische Universität Wien, Vienna
Centre Hôpital Universitaire Sart Tilman, Liège
Beaumont Hospital, Dublin
Mater Misericordiae University Hospital, Dublin
St. James's Hospital, Dublin
Galway University Hospital, Galway
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Albert Schweitzer Ziekenhuis, Dordrecht
Canisius Wilhelmina Ziekenhuis, Nijmegen
Papworth Hospital, Cambridge
University Hospital of Wales, Cardiff
St. Thomas Hospital, London
King's College Hospital London, London
Freeman, Newcastle-Upon-Tyne, Newcastle upon Tyne
Lead Sponsor
Collaborators (2)
Pharmaceutical Research Associates
OTHER
Medidata Solutions
INDUSTRY
Boston Scientific Corporation
INDUSTRY